Nutrition 21, LLC is a developer and marketer of efficacious, high-value, clinically substantiated ingredients for dietary supplements, medical foods, and beverages, including Velositol, an amylopectin/chromium dietary complex shown to amplify the effects of whey protein by significantly increasing muscle protein synthesis; Chromax, chromium picolinate, which supports increased glucose metabolism; and Nitrosigine, bonded arginine silicate, with FDA New Dietary Ingredient notification status and clinically shown to significantly boost nitric oxide levels. Nitric oxide is a key factor in increasing blood flow to working muscles. With many years of biotechnology and pharmaceutical experience, the company’s scientific platform has created unique, patented products that are safe and clinically effective. Rigorous preclinical and clinical trials are a key part of its product development strategy to ensure product safety and consumer trust. Nutrition 21 currently holds over 100 domestic and international issued and pending patents for products. Many support unique claims associated with, among others, glucose metabolism, weight management, brain health, cardiovascular health, and sports nutrition.